- Home
- VS vs APRE Comparison
VS vs APRE Comparison
Compare VS & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VS | APRE |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 6.9M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | VS | APRE |
|---|---|---|
| Price | $1.19 | $0.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 87.7K | 71.8K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,179,348.00 | $488,239.00 |
| Revenue This Year | $3,459.21 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2281.70 | N/A |
| 52 Week Low | $1.15 | $0.90 |
| 52 Week High | $3.79 | $5.00 |
Technical Indicators
Market Signals| Indicator | VS | APRE |
|---|---|---|
| Relative Strength Index (RSI) | 32.94 | 30.33 |
| Support Level | $1.20 | $0.90 |
| Resistance Level | $1.47 | $1.14 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 18.41 | 6.44 |
Price Performance
Historical ComparisonAbout VS Versus Systems Inc.
Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.
About APRE Aprea Therapeutics Inc.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.